-
公开(公告)号:US20210101944A1
公开(公告)日:2021-04-08
申请号:US16989654
申请日:2020-08-10
发明人: Xiaofeng LU , Hao YANG , Ze TAO , Jingqiu CHENG
IPC分类号: C07K14/315 , C07K14/705 , C07K16/28 , A61K38/17 , A61K38/16 , A61P35/00
摘要: A recombinant protein includes a TRAIL domain and an IgG binding domain IgBD. In the recombinant protein, IgBD can be fused at the N-terminus or C-terminus of the TRAIL domain. The anti-tumor effect of the recombinant protein after binding to endogenous or exogenous IgG is significantly stronger than that of TRAIL, and can be used in the treatment of cell proliferative diseases with high expression of death receptors.